Boston Scientific Profit Margin 2010-2025 | BSX

Current and historical gross margin, operating margin and net profit margin for Boston Scientific (BSX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Boston Scientific net profit margin as of March 31, 2025 is 11.58%.
Boston Scientific Annual Profit Margins
Boston Scientific Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $151.540B $16.747B
Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.329B 27.82
Stryker (SYK) United States $146.015B 30.53
EssilorLuxottica (ESLOY) France $127.709B 0.00
Medtronic (MDT) Ireland $109.786B 15.56
Lonza Group Ag (LZAGY) Switzerland $49.554B 0.00
Haleon (HLN) United Kingdom $49.214B 28.03
ResMed (RMD) United States $36.648B 27.53
Agilent Technologies (A) United States $32.650B 21.28
GE HealthCare Technologies (GEHC) United States $32.569B 15.46
Terumo (TRUMY) Japan $26.857B 34.88
Insulet (PODD) United States $22.464B 88.18
Koninklijke Philips (PHG) Netherlands $21.600B 15.53
Zimmer Biomet Holdings (ZBH) United States $18.095B 11.62
Baxter (BAX) United States $15.380B 11.48
Smith & Nephew SNATS (SNN) United Kingdom $12.819B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.043B 21.03
Lantheus Holdings (LNTH) United States $5.509B 13.90
Prestige Consumer Healthcare (PBH) United States $4.190B 18.72
Perrigo (PRGO) Ireland $3.610B 9.15
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.346B 15.24
ICU Medical (ICUI) United States $3.233B 23.84
Envista Holdings (NVST) United States $3.178B 26.41
GN Store Nord (GNNDY) Denmark $2.155B 17.85
QuidelOrtho (QDEL) United States $2.102B 14.46
LeMaitre Vascular (LMAT) United States $1.865B 41.69
AtriCure (ATRC) United States $1.729B 0.00
Acuren (TIC) United States $1.228B 0.00
AdaptHealth (AHCO) United States $1.196B 12.14
Green Thumb Industries (GTBIF) United States $1.101B 24.76
Neogen (NEOG) United States $1.077B 13.78
BioLife Solutions (BLFS) United States $1.046B 0.00
Kestra Medical Technologies (KMTS) United States $1.016B 0.00
Phibro Animal Health (PAHC) United States $0.972B 12.42
InMode (INMD) Israel $0.931B 9.38
Evolus (EOLS) United States $0.632B 0.00
CeriBell (CBLL) United States $0.619B 0.00
Curaleaf Holdings (CURLF) Canada $0.571B 0.00
Capricor Therapeutics (CAPR) United States $0.564B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.563B 0.00
Valneva SE (VALN) France $0.523B 0.00
Owens & Minor (OMI) United States $0.515B 4.27
Surmodics (SRDX) United States $0.429B 0.00
Tilray Brands (TLRY) Canada $0.412B 0.00
VAREX IMAGING (VREX) United States $0.340B 12.52
SNDL (SNDL) Canada $0.339B 0.00
Aurora Cannabis (ACB) Canada $0.313B 55.70
SEMPERIT AG HLD (SEIGY) Austria $0.291B 0.00
Cerus (CERS) United States $0.275B 0.00
Viemed Healthcare (VMD) United States $0.272B 22.90
Sanara MedTech (SMTI) United States $0.260B 0.00
ZimVie (ZIMV) United States $0.255B 11.61
Cresco Labs (CRLBF) United States $0.250B 0.00
Canopy Growth (CGC) Canada $0.239B 0.00
Sanuwave Health (SNWV) United States $0.231B 0.00
OraSure Technologies (OSUR) United States $0.217B 0.00
Quanterix (QTRX) United States $0.217B 0.00
Verano Holdings (VRNOF) United States $0.205B 0.00
Brainsway (BWAY) Israel $0.198B 52.30
Omeros (OMER) United States $0.196B 0.00
TriSalus Life Sciences (TLSI) United States $0.195B 0.00
Biote (BTMD) United States $0.194B 5.45
High Tide (HITI) Canada $0.188B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.80
Organigram Global (OGI) Canada $0.179B 0.00
Exagen (XGN) United States $0.157B 0.00
FitLife Brands (FTLF) United States $0.136B 16.72
Vireo Growth (VREOF) United States $0.125B 0.00
Jin Medical (ZJYL) China $0.121B 0.00
Veru (VERU) United States $0.096B 0.00
MacroGenics (MGNX) United States $0.095B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
Quipt Home Medical (QIPT) United States $0.092B 0.00
Fonar (FONR) United States $0.090B 11.56
TerrAscend (TSNDF) Canada $0.089B 0.00
Agape ATP (ATPC) $0.077B 0.00
InterCure (INCR) Israel $0.069B 0.00
Zynex (ZYXI) United States $0.065B 0.00
Apyx Medical (APYX) United States $0.063B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Modular Medical (MODD) United States $0.045B 0.00
United-Guardian (UG) United States $0.038B 13.02
Nephros (NEPH) United States $0.035B 47.43
Rockwell Medical (RMTI) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
Cellectar Biosciences (CLRB) United States $0.021B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00